Literature DB >> 7531465

Airborne cytotoxicity in the DiSC assay caused by solutions of treosulfan but not busulphan.

A G Bosanquet1, A R Burlton.   

Abstract

Treosulfan and busulphan are similar molecules, the former used in the treatment of ovarian cancer and the latter in chronic myelogenous leukaemia. We have used both in the differential staining cytotoxicity (DiSC) assay for in vitro drug sensitivity testing to aid in the choice of chemotherapy for individual patients. It was observed that occasionally the viability of control cells in one assay box was reduced compared with control cells in other boxes from the same assay. Treosulfan was suspected as the cause because cells throughout the microtitre box containing treosulfan had reduced viability in 28/62 (45%) experiments and in 9 of these, total kill of all cells in the box was observed. We tested the hypothesis that a metabolite of treosulfan might be the cause of this airborne cytotoxicity, and found that whilst 10 mg ml-1 of either methane sulphonic acid or tetrahydrofuran had no airborne cytotoxic effect, 1 mg ml-1 diepoxybutane killed over 95% of cells in all tubes in the same box. Treosulfan is another chemical (cf. azide, mafosfamide and possibly other cytotoxic agents) that can cause airborne cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531465     DOI: 10.1007/bf00754615

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  12 in total

Review 1.  Conditioning regimens for allogeneic bone marrow transplantation.

Authors:  E A Copelan
Journal:  Blood Rev       Date:  1992-12       Impact factor: 8.250

2.  Degradation of busulfan in aqueous solution.

Authors:  M Hassan; H Ehrsson
Journal:  J Pharm Biomed Anal       Date:  1986       Impact factor: 3.935

3.  Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies.

Authors:  M C Bird; A G Bosanquet; S Forskitt; E D Gilby
Journal:  Leuk Res       Date:  1986       Impact factor: 3.156

4.  4-Methanesulfonyloxybutanol: hydrolysis of busulfan.

Authors:  P W Feit; N Rastrup-Andersen
Journal:  J Pharm Sci       Date:  1973-06       Impact factor: 3.534

5.  Studies on epoxide formation from (2S,3S)-threitol 1,4-bismethanesulfonate. The preparation and biological activity of (2S,3S)-1,2-epoxy-3,4-butanediol 4-methanesulfonate.

Authors:  P W Feit; N Rastrup-Andersen; R Matagne
Journal:  J Med Chem       Date:  1970-11       Impact factor: 7.446

6.  Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay.

Authors:  A G Bosanquet
Journal:  Lancet       Date:  1991-03-23       Impact factor: 79.321

7.  In vitro drug sensitivity testing for the individual patient: an ideal adjunct to current methods of treatment choice.

Authors:  A G Bosanquet
Journal:  Clin Oncol (R Coll Radiol)       Date:  1993       Impact factor: 4.126

8.  Intravenous treosulfan versus intravenous treosulfan plus cisplatinum in advanced ovarian carcinoma.

Authors:  J Masding; T K Sarkar; W F White; V L Barley; S L Chawla; E Boesen; A Y Rostom; A P Menday
Journal:  Br J Obstet Gynaecol       Date:  1990-04

9.  Sodium azide is less suitable as a positive control of drug-induced lethality for in vitro clonogenic assays.

Authors:  P Lelieveld; M S Aapro; R van Lambalgen; K J van den Berg
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

10.  Release of a votile factor from solutions of oxazaphosphorines which damage normal and malignant cells.

Authors:  H Blomgren; M Hallström
Journal:  Methods Find Exp Clin Pharmacol       Date:  1989-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.